BioCentury
ARTICLE | Financial News

RXi completes follow-on

December 21, 2016 1:00 AM UTC

RXi raised $10 million through the sale of 2.1 million class A units at $0.90 and 8,082 class B units at $1,000 in a follow-on underwritten by Ladenburg Thalmann and Griffin Securities. Each class A u...

BCIQ Company Profiles

Phio Pharmaceuticals Corp.